Executive Vice President, Chief Technology Officer · HAEMONETICS CORP (HAE)

Anila Lingamneni

A named executive officer of HAEMONETICS in every fiscal year CompBrief holds from FY2021 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$2,542,417

Salary $485,070Stock awards $1,166,831

FY2023: $2,326,320

4th of 5 named executive officers at Haemonetics by FY2024 total.

5 named officers on file for HAEMONETICS, FY2024

Anila Lingamneni’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 4 equity grants, each cited to its filing
  • HAE’s disclosed peer group of 16 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how HAEMONETICS’s whole pay program stands against its peers

  • HAEMONETICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on HAE→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed June 7, 2024 (DEF 14A).

Free

Get Anila Lingamneni’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Anila Lingamneni compensation by year

HAEMONETICS Summary Compensation Table · all 3 fiscal years held
In US dollars, as HAEMONETICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2023FY2024
Salary$434,962$467,430$485,070
Bonus$100,000$0$0
Stock awards$649,518$987,437$1,166,831
Option awards$349,991$249,984$299,996
Non-equity incentive$276,963$598,801$564,909
Pension and deferred compensation$0$0$0
All other$33,403$22,668$25,611
Total$1,844,837$2,326,320$2,542,417

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: HAEMONETICS CORP DEF 14A filed June 7, 2024, accession 0000313143-24-000040, and prior-year filings. Open the filing on EDGAR.

How this page was built: the HAEMONETICS CORP filed document, accession 0000313143-24-000040. Every figure is read from that document and cited to the page and table it appears in. Filed June 7, 2024.

$1.8M
$2.3M
$2.5M
FY21
FY23
FY24
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
PSU8,680$740,838—
PSU7,070$603,425—
PSU6,729$574,320—
RSU3,364$287,117—
RSU3,255$277,814—
RSU1,768$150,899—
RSU546$46,601—
RSU303$25,861—
Option7,602—$89.16
Option1,878—$103.12
Option1,023—$103.37
Option4,782—$56.57

Per the Outstanding Equity Awards at Fiscal Year-End table in HAEMONETICS CORP's FY2024 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 13 award rows shown.

Change-in-control & termination

estimated payments HAEMONETICS discloses, by trigger · FY2023
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Involuntary for cause$0$0$0$0
Change in control and involuntary termination$1,520,033$2,957,867$51,866$4,544,766
Voluntary resignation$0$0$0$0
Involuntary termination without cause$1,059,417$0$20,393$1,094,810
Disability$0$2,219,590$0$2,219,590
Death$0$2,219,590$0$2,219,590

Per the Potential Payments Upon Termination or Change in Control table in HAEMONETICS CORP's FY2023 proxy. Estimates as the company printed them; a dash means it printed no figure.

HAEMONETICS’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Christopher SimonPresident and Chief Executive Officer$11,545,113
James D'AreccaExecutive Vice President, Chief Financial Officer$3,146,059
Michelle BasilExecutive Vice President, General Counsel$3,071,403
Anila Lingamneni · this pageExecutive Vice President, Chief Technology Officer$2,542,417
Josep LlorensExecutive Vice President, Global Manufacturing and Supply Chain$2,429,010

The full HAEMONETICS compensation record

free company brief

This page is one person within HAEMONETICS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the HAEMONETICS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are HAEMONETICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Anila Lingamneni's compensation dossier · One-time report. No refunds.